For this, two specimens of adenocarcinomas arising in the background of BE were assessed for the expression of CDX2, OLFM4, EPHB2, and PROM1 by qRT-PCR analysis (Fig 4A). The gene discussed is CDX2; the disease is adenocarcinoma.